Laboratory Co. of America Holdings (NYSE:LH) Stock Holdings Increased by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Laboratory Co. of America Holdings (NYSE:LHFree Report) by 15.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 17,815 shares of the medical research company’s stock after acquiring an additional 2,363 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Laboratory Co. of America were worth $3,582,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Lazard Asset Management LLC boosted its holdings in Laboratory Co. of America by 532.2% during the fourth quarter. Lazard Asset Management LLC now owns 1,530,675 shares of the medical research company’s stock valued at $360,441,000 after acquiring an additional 1,288,574 shares during the period. Diamond Hill Capital Management Inc. lifted its position in shares of Laboratory Co. of America by 644.2% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,280,884 shares of the medical research company’s stock worth $257,522,000 after purchasing an additional 1,108,776 shares during the last quarter. Norges Bank bought a new stake in Laboratory Co. of America during the 4th quarter valued at approximately $219,236,000. Allspring Global Investments Holdings LLC grew its holdings in Laboratory Co. of America by 3,836.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 806,975 shares of the medical research company’s stock valued at $162,243,000 after buying an additional 786,477 shares during the last quarter. Finally, BlackRock Inc. increased its position in Laboratory Co. of America by 6.2% in the 2nd quarter. BlackRock Inc. now owns 12,703,935 shares of the medical research company’s stock worth $3,065,841,000 after buying an additional 743,824 shares during the period. Institutional investors own 89.37% of the company’s stock.

Laboratory Co. of America Stock Up 2.2 %

Shares of Laboratory Co. of America stock opened at $227.50 on Tuesday. The company has a quick ratio of 1.20, a current ratio of 1.36 and a debt-to-equity ratio of 0.57. Laboratory Co. of America Holdings has a 12 month low of $174.20 and a 12 month high of $234.09. The stock has a market cap of $19.31 billion, a PE ratio of 30.41 and a beta of 1.04. The business has a fifty day simple moving average of $223.60 and a 200 day simple moving average of $213.28.

Laboratory Co. of America Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 13th. Investors of record on Tuesday, February 27th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 1.27%. The ex-dividend date is Monday, February 26th. Laboratory Co. of America’s payout ratio is 38.50%.

Insider Activity at Laboratory Co. of America

In other news, CAO Peter J. Wilkinson sold 1,384 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $210.71, for a total transaction of $291,622.64. Following the completion of the sale, the chief accounting officer now owns 2,087 shares of the company’s stock, valued at $439,751.77. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Der Vaart Sandra D. Van sold 259 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $222.06, for a total transaction of $57,513.54. Following the completion of the transaction, the executive vice president now directly owns 7,637 shares of the company’s stock, valued at approximately $1,695,872.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Peter J. Wilkinson sold 1,384 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $210.71, for a total transaction of $291,622.64. Following the completion of the sale, the chief accounting officer now directly owns 2,087 shares in the company, valued at approximately $439,751.77. The disclosure for this sale can be found here. Corporate insiders own 0.65% of the company’s stock.

Analysts Set New Price Targets

LH has been the subject of several research reports. TheStreet raised Laboratory Co. of America from a “c+” rating to a “b-” rating in a research report on Thursday, January 18th. Evercore ISI initiated coverage on shares of Laboratory Co. of America in a report on Friday. They set an “in-line” rating and a $240.00 price objective on the stock. Barclays initiated coverage on shares of Laboratory Co. of America in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $222.00 target price for the company. JPMorgan Chase & Co. lifted their target price on Laboratory Co. of America from $259.00 to $261.00 and gave the stock an “overweight” rating in a research report on Friday, November 17th. Finally, Mizuho cut their price target on Laboratory Co. of America from $257.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, October 31st. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Laboratory Co. of America currently has a consensus rating of “Moderate Buy” and an average target price of $241.86.

View Our Latest Stock Report on LH

Laboratory Co. of America Profile

(Free Report)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development.

See Also

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings (NYSE:LHFree Report).

Institutional Ownership by Quarter for Laboratory Co. of America (NYSE:LH)

Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.